AboutÂ
Fagron UK
Together we enable pharmacists, prescribers, hospitals and industry
 to provide quality, safety and service for their patients.Â
As a leading global company in pharmaceutical preparations, Fagron aims to make personalized medication available to hospitals, pharmacists and patients worldwide.
Fagron, FArmaceutische GRONdstoffen, was founded in Rotterdam in 1990 and has been listed on Euronext Brussels and Amsterdam since October 5, 2007. Fagron is now active in 34 countries across 5 continents. More than 3,000 FTE, including more than 400 pharmacists, work every day on innovative solutions and concepts that meet the needs of pharmacists, prescribers and patients.
Togeher we create the future of personalizing medicine
Compounding essentials
Brands
Compounding services for pharmacies
Academy
Demographic Factors
A growing world population, increasingly higher life expectancy and ageing population.It is Fagron’s focus to make and keep medicine available as widely and consistently as possible.
Personalization
Pharmaceutical Compounding allows pharmacist and prescriber to create medication that satisfies the individual needs of the patient.Extending the range of mass-produced medication through personalization, together we can cater to every patient.
Accessibility
By personalizing medicine, they become accessible to even more people.By keeping medication that is no longer offered commercially available and affordable for those who need them. By resolving (temporary) drug shortages through government issued requests.
Sustainability
We embed Environmental, Social and Governance (ESG) into the core of our organization.Responsible use and conservation of the natural environment.
Manage our relationships with internal and external stakeholders responsibly & honorably.
Quality & Safety
Our in-house expertise and mechanisms allow us to ensure our products meet all the necessary standards.
About Fagron UK
 to provide quality, safety and service for their patients.Â
As a leading global company in pharmaceutical preparations, Fagron aims to make personalized medication available to hospitals, pharmacists and patients worldwide.
Fagron, FArmaceutische GRONdstoffen, was founded in Rotterdam in 1990 and has been listed on Euronext Brussels and Amsterdam since October 5, 2007. Fagron is now active in 34 countries across 5 continents. More than 3,000 FTE, including more than 400 pharmacists, work every day on innovative solutions and concepts that meet the needs of pharmacists, prescribers and patients.
Togeher we create the future of personalizing medicine
Compounding essentials
Brands
Compounding services for pharmacies
Academy
Demographic Factors
A growing world population, increasingly higher life expectancy and ageing population.It is Fagron’s focus to make and keep medicine available as widely and consistently as possible.
Personalization
Pharmaceutical Compounding allows pharmacist and prescriber to create medication that satisfies the individual needs of the patient.Extending the range of mass-produced medication through personalization, together we can cater to every patient.
Accessibility
By personalizing medicine, they become accessible to even more people.By keeping medication that is no longer offered commercially available and affordable for those who need them. By resolving (temporary) drug shortages through government issued requests.
Sustainability
We embed Environmental, Social and Governance (ESG) into the core of our organization.Responsible use and conservation of the natural environment.
Manage our relationships with internal and external stakeholders responsibly & honorably.
